Global Cytomegalovirus Infection Market Research Report 2023

Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.

The global Cytomegalovirus Infection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.

This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus Infection.

The Cytomegalovirus Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cytomegalovirus Infection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cytomegalovirus Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cytomegalovirus Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cidofovir

1.2.3 Foscarnet

1.2.4 Valganciclovir

1.2.5 Ganciclovir

1.3 Market by Application

1.3.1 Global Cytomegalovirus Infection Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Cytomegalovirus Infection Market Perspective (2018-2029)

2.2 Cytomegalovirus Infection Growth Trends by Region

2.2.1 Global Cytomegalovirus Infection Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Cytomegalovirus Infection Historic Market Size by Region (2018-2023)

2.2.3 Cytomegalovirus Infection Forecasted Market Size by Region (2024-2029)

2.3 Cytomegalovirus Infection Market Dynamics

2.3.1 Cytomegalovirus Infection Industry Trends

2.3.2 Cytomegalovirus Infection Market Drivers

2.3.3 Cytomegalovirus Infection Market Challenges

2.3.4 Cytomegalovirus Infection Market Restraints

3.1 Global Top Cytomegalovirus Infection Players by Revenue

3.1.1 Global Top Cytomegalovirus Infection Players by Revenue (2018-2023)

3.1.2 Global Cytomegalovirus Infection Revenue Market Share by Players (2018-2023)

3.2 Global Cytomegalovirus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cytomegalovirus Infection Revenue

3.4 Global Cytomegalovirus Infection Market Concentration Ratio

3.4.1 Global Cytomegalovirus Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Infection Revenue in 2022

3.5 Cytomegalovirus Infection Key Players Head office and Area Served

3.6 Key Players Cytomegalovirus Infection Product Solution and Service

3.7 Date of Enter into Cytomegalovirus Infection Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cytomegalovirus Infection Historic Market Size by Type (2018-2023)

4.2 Global Cytomegalovirus Infection Forecasted Market Size by Type (2024-2029)

5.1 Global Cytomegalovirus Infection Historic Market Size by Application (2018-2023)

5.2 Global Cytomegalovirus Infection Forecasted Market Size by Application (2024-2029)

6.1 North America Cytomegalovirus Infection Market Size (2018-2029)

6.2 North America Cytomegalovirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Cytomegalovirus Infection Market Size by Country (2018-2023)

6.4 North America Cytomegalovirus Infection Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Cytomegalovirus Infection Market Size (2018-2029)

7.2 Europe Cytomegalovirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Cytomegalovirus Infection Market Size by Country (2018-2023)

7.4 Europe Cytomegalovirus Infection Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Cytomegalovirus Infection Market Size (2018-2029)

8.2 Asia-Pacific Cytomegalovirus Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Cytomegalovirus Infection Market Size by Region (2018-2023)

8.4 Asia-Pacific Cytomegalovirus Infection Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Cytomegalovirus Infection Market Size (2018-2029)

9.2 Latin America Cytomegalovirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Cytomegalovirus Infection Market Size by Country (2018-2023)

9.4 Latin America Cytomegalovirus Infection Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Cytomegalovirus Infection Market Size (2018-2029)

10.2 Middle East & Africa Cytomegalovirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Cytomegalovirus Infection Market Size by Country (2018-2023)

10.4 Middle East & Africa Cytomegalovirus Infection Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Cytomegalovirus Infection Introduction

11.1.4 Roche Revenue in Cytomegalovirus Infection Business (2018-2023)

11.1.5 Roche Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Detail

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Cytomegalovirus Infection Introduction

11.2.4 GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2018-2023)

11.2.5 GlaxoSmithKline Recent Development

11.3 Vical

11.3.1 Vical Company Detail

11.3.2 Vical Business Overview

11.3.3 Vical Cytomegalovirus Infection Introduction

11.3.4 Vical Revenue in Cytomegalovirus Infection Business (2018-2023)

11.3.5 Vical Recent Development

11.4 AiCuris Anti-Infective Cures

11.4.1 AiCuris Anti-Infective Cures Company Detail

11.4.2 AiCuris Anti-Infective Cures Business Overview

11.4.3 AiCuris Anti-Infective Cures Cytomegalovirus Infection Introduction

11.4.4 AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2018-2023)

11.4.5 AiCuris Anti-Infective Cures Recent Development

11.5 ViroPharma

11.5.1 ViroPharma Company Detail

11.5.2 ViroPharma Business Overview

11.5.3 ViroPharma Cytomegalovirus Infection Introduction

11.5.4 ViroPharma Revenue in Cytomegalovirus Infection Business (2018-2023)

11.5.5 ViroPharma Recent Development

11.6 Chimerix

11.6.1 Chimerix Company Detail

11.6.2 Chimerix Business Overview

11.6.3 Chimerix Cytomegalovirus Infection Introduction

11.6.4 Chimerix Revenue in Cytomegalovirus Infection Business (2018-2023)

11.6.5 Chimerix Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Cytomegalovirus Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cidofovir

    Table 3. Key Players of Foscarnet

    Table 4. Key Players of Valganciclovir

    Table 5. Key Players of Ganciclovir

    Table 6. Global Cytomegalovirus Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Cytomegalovirus Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Cytomegalovirus Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Cytomegalovirus Infection Market Share by Region (2018-2023)

    Table 10. Global Cytomegalovirus Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Cytomegalovirus Infection Market Share by Region (2024-2029)

    Table 12. Cytomegalovirus Infection Market Trends

    Table 13. Cytomegalovirus Infection Market Drivers

    Table 14. Cytomegalovirus Infection Market Challenges

    Table 15. Cytomegalovirus Infection Market Restraints

    Table 16. Global Cytomegalovirus Infection Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Cytomegalovirus Infection Market Share by Players (2018-2023)

    Table 18. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2022)

    Table 19. Ranking of Global Top Cytomegalovirus Infection Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Cytomegalovirus Infection Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Cytomegalovirus Infection Product Solution and Service

    Table 23. Date of Enter into Cytomegalovirus Infection Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Cytomegalovirus Infection Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Cytomegalovirus Infection Revenue Market Share by Type (2018-2023)

    Table 27. Global Cytomegalovirus Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Cytomegalovirus Infection Revenue Market Share by Type (2024-2029)

    Table 29. Global Cytomegalovirus Infection Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Cytomegalovirus Infection Revenue Market Share by Application (2018-2023)

    Table 31. Global Cytomegalovirus Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Cytomegalovirus Infection Revenue Market Share by Application (2024-2029)

    Table 33. North America Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Cytomegalovirus Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Cytomegalovirus Infection Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Cytomegalovirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Cytomegalovirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Roche Company Detail

    Table 49. Roche Business Overview

    Table 50. Roche Cytomegalovirus Infection Product

    Table 51. Roche Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 52. Roche Recent Development

    Table 53. GlaxoSmithKline Company Detail

    Table 54. GlaxoSmithKline Business Overview

    Table 55. GlaxoSmithKline Cytomegalovirus Infection Product

    Table 56. GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 57. GlaxoSmithKline Recent Development

    Table 58. Vical Company Detail

    Table 59. Vical Business Overview

    Table 60. Vical Cytomegalovirus Infection Product

    Table 61. Vical Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 62. Vical Recent Development

    Table 63. AiCuris Anti-Infective Cures Company Detail

    Table 64. AiCuris Anti-Infective Cures Business Overview

    Table 65. AiCuris Anti-Infective Cures Cytomegalovirus Infection Product

    Table 66. AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 67. AiCuris Anti-Infective Cures Recent Development

    Table 68. ViroPharma Company Detail

    Table 69. ViroPharma Business Overview

    Table 70. ViroPharma Cytomegalovirus Infection Product

    Table 71. ViroPharma Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 72. ViroPharma Recent Development

    Table 73. Chimerix Company Detail

    Table 74. Chimerix Business Overview

    Table 75. Chimerix Cytomegalovirus Infection Product

    Table 76. Chimerix Revenue in Cytomegalovirus Infection Business (2018-2023) & (US$ Million)

    Table 77. Chimerix Recent Development

    Table 78. Research Programs/Design for This Report

    Table 79. Key Data Information from Secondary Sources

    Table 80. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Cytomegalovirus Infection Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Cytomegalovirus Infection Market Share by Type: 2022 VS 2029

    Figure 3. Cidofovir Features

    Figure 4. Foscarnet Features

    Figure 5. Valganciclovir Features

    Figure 6. Ganciclovir Features

    Figure 7. Global Cytomegalovirus Infection Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Cytomegalovirus Infection Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Retail Pharmacies Case Studies

    Figure 11. Online Pharmacies Case Studies

    Figure 12. Cytomegalovirus Infection Report Years Considered

    Figure 13. Global Cytomegalovirus Infection Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Cytomegalovirus Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Cytomegalovirus Infection Market Share by Region: 2022 VS 2029

    Figure 16. Global Cytomegalovirus Infection Market Share by Players in 2022

    Figure 17. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus Infection as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2022

    Figure 19. North America Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Cytomegalovirus Infection Market Share by Country (2018-2029)

    Figure 21. United States Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Cytomegalovirus Infection Market Share by Country (2018-2029)

    Figure 25. Germany Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Cytomegalovirus Infection Market Share by Region (2018-2029)

    Figure 33. China Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Cytomegalovirus Infection Market Share by Country (2018-2029)

    Figure 41. Mexico Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Cytomegalovirus Infection Market Share by Country (2018-2029)

    Figure 45. Turkey Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Cytomegalovirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Roche Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 48. GlaxoSmithKline Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 49. Vical Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 50. AiCuris Anti-Infective Cures Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 51. ViroPharma Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 52. Chimerix Revenue Growth Rate in Cytomegalovirus Infection Business (2018-2023)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed